Quaker Chemical (KWR) Q4 2024 earnings summary

Executive summary

• Entered 2025 with a strong margin profile, robust operating cash flow, and improved customer focus, despite persistent end market softness and regional contractions.

• Q4 2024 net sales were $444.1M, adjusted EBITDA $64.8M, and non-GAAP EPS $1.33; full year net sales $1.84B, adjusted EBITDA $310.9M, and non-GAAP EPS $7.44.

• Completed integration of Quaker and Houghton, made internal improvements, and executed a demanding transformation agenda.

• Organic sales volumes in Q4 2024 declined slightly year-over-year, mainly due to softer end market conditions in the Americas and EMEA, partially offset by Asia/Pacific growth and new business wins.

• Adjusted EBITDA for Q4 2024 decreased compared to Q4 2023, reflecting lower segment operating margins and weaker demand in key regions.

Financial highlights

• Q4 2024 net sales declined 5% year-over-year to $444.1M; full year net sales down 5.8% to $1,839.7M.

• Q4 2024 gross margin was 35.2%, impacted by manufacturing absorption, raw material costs, and mix; issues largely resolved in January.

• Q4 2024 adjusted EBITDA was $64.8M (14.6% margin), down 15.9% year-over-year; full year adjusted EBITDA was $310.9M (16.9% margin), down 3% year-over-year.

• Q4 2024 GAAP net income was $14.2M (EPS $0.81); non-GAAP net income was $23.6M (EPS $1.33). Full year GAAP net income was $116.7M (EPS $6.51); non-GAAP net income $133.5M (EPS $7.44).

• Operating cash flow for 2024 was $205M.

Outlook and guidance

• Revenue, adjusted EBITDA, and earnings growth anticipated in 2025, with another strong year of cash flow generation.

• At least $20M in run-rate cost savings expected in 2025 from complexity reduction initiatives.

• Gross margins expected to be comparable to 2024; Q1 to see seasonal improvement in demand and margins.

• FX expected to be a low single-digit headwind to sales in 2025.

• Raw material costs expected to stabilize in 2025.